Alaunos Therapeutics reported 0 in Cost of Sales for its fiscal quarter ending in September of 2024.


Cost Of Sales Change Date
Adcock Ingram Holdings ZAR 3.18B 115.21M Dec/2024
Alaunos Therapeutics 0 18K Sep/2024
Amgen USD 3.01B 406M Jun/2025
AstraZeneca USD 2.47B 232M Jun/2025
Baxter International USD 1.82B 55M Jun/2025
Biogen USD 605M 24.3M Jun/2025
Bioline Rx USD 72K 38K Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Celltrion KRW 399.04B 120.81B Mar/2025
Corcept Therapeutics USD 3.43M 1.03M Jun/2025
Cspc Pharmaceutical CNY 2.31B 299.94M Mar/2025
Divis Laboratories Ltd 10.68B 870M Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Incyte USD 78.77M 10.96M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
J&J USD 7.6B 304M Jun/2025
Kangmei Pharma CNY 1.03B 35.75M Jun/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Laboratorios Farma EUR 54.41M 97.64M Jun/2025
Malin Corporation EUR 15.4M 0 Dec/2020
Medical Developments International AUD 5.27M 2.92M Dec/2024
Merck USD 2.82B 53M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Organigram Holdings CAD 44.65M 2.96M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Pharma Mar EUR 2.78M 620K Jun/2025
PTC Therapeutics USD 15.48M 2.62M Jun/2025
Qiagen NV USD 199.25M 24.48M Jun/2025
Regeneron Pharmaceuticals USD 530.2M 264.7M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sartorius EUR 468.1M 16.1M Jun/2025
Sino Biopharmaceutical CNY 2.49B 353.34M Dec/2024
TG Therapeutics USD 18.94M 3.4M Jun/2025
Tilray USD 149.73M 9.39M Nov/2024
Zz Pientze Pharmaceu 1.94B 214.76M Jun/2025